Altre lingue Universal Biosensors, Inc.

Azioni

UBI

AU000000UBI2

Mercato chiuso - Australian S.E. Altri mercati azionari 07:50:07 26/04/2024			Variaz. 5gg	Var. 1 gen.
0,15 ^AUD	-11,76%		-9,09%	-25,00%

11/04	Universal Biosensors raccoglierà 10 milioni di dollari australiani per lo sviluppo tecnologico	MT
10/04	Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Universal Biosensors Opens AU$10 Million Rights Issue	19/04
Universal Biosensors to Raise AU$10 Million for Technology Development	11/04
H&G High Conviction Reports Flat Performance for March Quarter	10/04
Australian Shares Rise as Central Bank Maintains Interest Rates	19/03
Universal Biosensors Secures US FDA Approval for Coagulation Analyzer Device; Shares Surge 78%	19/03
Universal Biosensors Narrows 2023 Loss on Absence of Impairment, Higher Revenue; Shares Down 6%	01/03
Universal Biosensors, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Universal Biosensors Grows H2 2023 Sales by 55%	31/01
Universal Biosensors, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/10/23
Universal Biosensors' Coagulation Analysis Device Gets Approval in Europe	04/10/23
Universal Biosensors Secures Marketing Approval, First Order for Coagulation Analyzer Device in India	31/08/23
Universal Biosensors Secures First Major Tender to Supply Xprecia Prime in Italy	09/08/23
Australian Shares Flat Ahead of Central Bank Policy Meeting	31/07/23
Universal Biosensors Narrows Net Loss 74% in H1	31/07/23
Universal Biosensors, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	31/07/23
Universal Biosensors, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/07/23
Universal Biosensors Trims Q1 Loss on Lower Expenses, Absence of Intangible Assets Impairment	11/05/23
Universal Biosensors, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
Universal Biosensors Launches Blood Glucose Monitoring Product for Dogs and Cats	03/05/23
Universal Biosensors Introduces Sixth Product on Sentia Wine Testing Platform	20/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Universal Biosensors, Inc.

Azioni

UBI

AU000000UBI2

Altre lingue

Filtri